Lentiviral hematopoietic stem cell gene therapy (atidarsagene autotemcel) for late juvenile metachromatic leukodystrophy (MLD)MOLECULAR GENETICS AND METABOLISMIF3.52024-02-010PRE
Atidarsagene autotemcel (autologous hematopoietic stem cell gene therapy) preserves cognitive and motor development in early-onset metachromatic leukodystrophy with up to 12 years follow-upMOLECULAR GENETICS AND METABOLISMIF3.52024-02-010PRE
Hemophagocytic inflammatory syndrome in ADA-SCID: report of two cases and literature reviewFRONTIERS IN IMMUNOLOGYIF5.92023-06-263OAAI
Blood sulfatides as disease biomarker for metachromatic leukodystrophy: Disease characterization, early diagnosis, and response to treatmentMOLECULAR GENETICS AND METABOLISMIF3.52023-02-010PRE
Long-term clinical outcomes of atidarsagene autotemcel (autologous hematopoietic stem cell gene therapy [HSC-GT] for metachromatic leukodystrophy) with up to 11 years follow-upMOLECULAR GENETICS AND METABOLISMIF3.52023-02-010PRE
Lentiviral haematopoietic stem cell gene therapy for metachromatic leukodystrophy: Results in 5 patients treated under nominal compassionate useMOLECULAR GENETICS AND METABOLISMIF3.52023-02-010PRE
Lentiviral hematopoietic stem and progenitor cell gene therapy provides durable clinical benefit in early-symptomatic early-juvenile metachromatic leukodystrophyMOLECULAR GENETICS AND METABOLISMIF3.52021-02-012PREAI
Lentiviral haematopoietic stem cell gene therapy for metachromatic leukodystrophy: Results in nine patients treated with a cryopreserved formulation of OTL-200MOLECULAR GENETICS AND METABOLISMIF3.52021-02-011PREAI
Mild SARS-CoV-2 Infection After Gene Therapy in a Child With Wiskott-Aldrich Syndrome: A Case ReportFRONTIERS IN IMMUNOLOGYIF5.92020-11-249OAAI
Emapalumab treatment in an ADA-SCID patient with refractory hemophagocytic lymphohistiocytosis-related graft failure and disseminated bacillus Calmette-Guerin infectionHAEMATOLOGICAIF7.92020-08-1318OAAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向